Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Sep 15, 2022 9:59am
107 Views
Post# 34964149

RE:RE:RE:RE:RE:RE:RE:AUG 24 AGM cancelled

RE:RE:RE:RE:RE:RE:RE:AUG 24 AGM cancelledThe transparency of this company has become a pathetic joke.

 Why in hell is everything a mystery:

Are they going to have an AGM or an SGM on Oct. 31th ?  The shareholders have a right to know what kind of meeting this is.  If it is a SGM, what type of resolution is being voted on ? Is the company being sold ?  Are they anticipating some sort of a deal with Shiseido regarding RCH-01 in Asia ?  If it is not an SGM they should be sending the shareholders information on an AGM.

What is happening with this Arbitration ?  We as shareholders know absolutely nothing of how this is progressing.  Shouldn't we have some idea of the process especially with so much riding on the outcome ?  Does this Arbitration end on or near Oct. 18th ?  We have been led to believe this is the case. 

Where are we at with the Dermal Injector, their only near term commercial asset ?  Lots of tweets last Fall as well as this Spring now very little information.  We recently heard testing has proven  the device works but yet it is not being submitteed for FDA Approval. What is the hold up?   Would it hurt for us shareholders to have a more accurate idea of when they anticipate submission ?

 For years we have heard about potential Trials in China and Japan for RCT-01 and RCS-01 but nothing ever happens.  How many times have we herd they are pursuing partnerships in Japan but nothing ever comes of it.  Then there is Yofoto : "much to do about nothing".  Years and years of no activity.  Is there an explanation for that ?

Endless Private Placements with insiders buying cheap shares diluting the share count for the rest of us.  Trading endlessly at these ridiculous levels.

Have I covered everything....this company has become a joke and unfortunately I have a large load of shares in this P.O.S. 

Answer the frigging questions above and let the shareholders make some informed decisions whether they want to continue holding shares in this company.
















<< Previous
Bullboard Posts
Next >>